BREAKOUT STOCK ALERT UPDATE
$VYGR - Voyager Therapeutics, Inc. - Common Stock
Initial Alert Price: $8.38
Price High: $7.19
% Gains/Losses: -14.2%
(-29.63% Less Than Expected)
Potential Stop Loss: $6.8305
VYGR is currently trading below our 10% Sell Threshold but we have are watching to determine if the stock breaks below the current support levels around the...
Voyager Therapeutics Inc is functional in the United States biotechnology industry. Its focus lies in the research and development of gene therapies for the cure of severe diseases of the central nervous system such as the Parkinson's, Huntington's and Alzheimer's disease. The company has developed products such as VY-AADC01 for Advanced Parkinson's Disease,...
Voyager therapeutics could jump up on another surprise earnings
The 50 day Moving average is below the 100 and 200 day moving - volume is up
and earnings have amazing earnings up 60% and 1300% these last few quarters so.... it might turn around - I am not buying at this price though.
How long can you out perform with your stock falling ?
I don't know.
The stock has never been cheaper (except covid crash) so it looks like a nice opportunity for a long.
Moreover there is a gap to be filled.
Going long with a tight stop - might be a nice reward without too much risk.
Possible stop below 9.8
Not a recommendation
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's disease. Its...
this stock has taken a beating and will rise again
the RSI is very low and earnings are set to come on AUG 10th.
It looks like everyone thinks the report will be bad - I will buy again if it dips to 9.50 , 9 or even 8.
VYGR has reached a strong support area while the RSI has had higher lows indicating accumulation. The MACD is also increasing and is almost positive.
Expecting the price to increase steadily soon.
Look out for the bull cross of EMA9 of EMA21. This will accelerate the price rise.
The next earnings are on Feb 26.
Coming up from a recent trend change after a bear trend since march 18
Bullish news, Three EMA crossover, and above ichimoku clouds
Potential retracement can happen nevertheless long term this is looking strong
Dark pools may be responsible for recent overselling w/2 near-term catalysts: 4/25 (presentation of its Phase 1b PD drug results at AAN Annual Meeting), 5/11 (earnings). Its PD (VY-AADC01) will shake the market if its phase 1b results can be replicated. Price should correct to $14-15 after a couple weeks. NASDAQ:VYGR